Immuno Cure BioTech acquires Shanghai Teresa Healthcare
Integrating Electroporation Technology & DNA Vaccine Platforms HONG KONG SAR – Media OutReach – 20 September 2022 – Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China. The transaction will be settled in cash and shares. […]